AndrewC. Flick, Hong X. Ding, Carolyn A. Leverett, Sarah J. Fink, Christopher J. O’Donnell
Index: 10.1021/acs.jmedchem.8b00260
Full Text: HTML
New drugs introduced to the market every year represent privileged structures for particular biological targets. These new chemical entities provide insight into molecular recognition while serving as leads for designing future new drugs. This annual review describes the most likely process-scale synthetic approaches to 19 new chemical entities that were approved for the first time in 2016.
An 18F-Labeled Poly(ADP-ribose) Polymerase Positron Emission...
2018-04-19 [10.1021/acs.jmedchem.8b00138] |
An Efficient Buchwald–Hartwig/Reductive Cyclization for the ...
2018-04-19 [10.1021/acs.jmedchem.7b01903] |
Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhib...
2018-04-18 [10.1021/acs.jmedchem.8b00232] |
New Inhibitors of Breast Cancer Resistance Protein (ABCG2) C...
2018-04-18 [10.1021/acs.jmedchem.7b01012] |
Computer-Aided Discovery and Characterization of Novel Ebola...
2018-04-17 [10.1021/acs.jmedchem.8b00035] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved